October 13, 2016 / 6:12 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Fluidigm, Flex Pharma, Contravir Pharma

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s)

The S&P 500 and the Dow Jones Industrial average touched three-month lows on Thursday, dragged down by weak Chinese economic data and the prospects of a U.S. interest rate hike by the end of the year.

The Dow Jones Industrial Average was down 0.18 percent at 18,111.91, the S&P 500 was down 0.19 percent at 2,135.08 and the Nasdaq Composite was down 0.38 percent at 5,219.081.

** FLUIDIGM CORP, $5.05, -28.37 pct

The life sciences research company estimated a 23 percent drop in third-quarter revenue due to lower-than-expected sales of Helios systems.

** FLEX PHARMA INC, $8.92, -20.36 pct

Prelim analysis of trial data on Flex’s experimental nocturnal leg cramps drug showed that it did not confer a statistically significant benefit on muscle-cramp frequency.


The antiviral drug developer posted positive interim data from an ongoing mid-stage study on its experimental hepatitis B drug.

** TG THERAPEUTICS INC, $6.98, -15.39 pct

The drug developer said it was revising a trial design for a late-stage study for its drug to treat types of cancer that begin in cells of blood-forming tissue.


The trucking company forecast a big drop in third-quarter earnings, citing higher depreciation and claims expense.

** OCULAR THERAPEUTIX INC, $7.27, +15.21 pct


The eye-drug developer entered into a collaboration with Regeneron Pharmaceuticals to develop a treatment for wet age-related macular degeneration and other serious retinal diseases.

** APTOSE BIOSCIENCES INC, $2.43, -12.34 pct

The Canadian drug developer said FDA requested additional information about clinical hold, placed on early-stage trial of its cancer drug in November.

** LONG ISLAND ICED TEA CORP, $5.2999, +14.47 pct

The iced tea maker signed a deal to sell its drinks at over 1,000 Food Lion supermarkets.

** AETERNA ZENTARIS INC, $4.2862, +12.79 pct

The Canadian drug developer signed a license agreement to market its cancer drug, Zoptrex, in Australia and New Zealand with privately held Specialised Therapeutics Asia.

** LINDSAY CORP, $77.82, +12.29 pct

The water filtration equipment maker posted better-than-expected quarterly profit and revenue, citing improved demand in both its irrigation and road infrastructure segments.

** CLUBCORP HOLDINGS INC, $12.62, -10.05 pct

The private golf and country club owner reported third-quarter revenue that fell short of analysts’ estimates.

** CUBIC CORP, $40.59, -9.84 pct

The systems operator estimated sales of $1.46 billion for the year ended Sept. 30, lower than its previous forecast of $1.51 to $1.56 billion.

** MERCADOLIBRE INC, $169.23, -7.63 pct

** EBAY INC, $31.46, -0.13 pct

EBay looks to slash its stake by two thirds in the South American e-commerce tech company, MercadoLibre.


The company reported lower-than-expected third-quarter revenue and profit due to lower demand in Europe, its second-biggest market.

** DECKERS OUTDOOR CORP, $57.3, -6.03 pct

Brokerage Susquehanna downgraded the footwear and apparel maker’s stock to “negative” from “neutral.”

** GOPRO INC, $13.665, -4.44 pct

The wearable device maker temporarily stopped supplying to Amazon.com, Piper Jaffray analyst Erinn Murphy said.

** SIBANYE GOLD LTD, $11.64, +5.53 pct

** GOLD FIELDS LTD, $4.26, +4.93 pct

** HARMONY GOLD MINING, $3, +3.09 pct

** YAMANA GOLD, $3.8, +2.15 pct

** GOLDCORP, $14.73, +2.72 pct

U.S-listed shares of gold miners rose in premarket trading as bullion gained on weaker dollar and slump in equities following soft Chinese trade data.

** BANK OF AMERICA CORP, $15.795, -1.47 pct

** CITIGROUP INC, $48.34, -0.74 pct

** JPMORGAN CHASE & CO, $67.6, -0.78 pct

** DEUTSCHE BANK, $13.395, -1.51 pct

U.S. banks fall as Fed’s lack of clarity on timing for the next rate hike and Deutsche Bank’s hiring freeze weighed on stocks.

** WELLS FARGO & CO, $44.59, -1.61 pct

Wells Fargo & Co’s Chairman and Chief Executive Officer, John Stumpf, abruptly departed on Wednesday, bowing to pressure over its sales tactics that has damaged the bank’s reputation and put Wall Street under renewed scrutiny.

** PFIZER INC, $32.82, -0.76 pct

Pfizer suffered a setback in Britain when the Court of Appeal in London ruled against it in a patent case over the use of its $5 billion-a-year drug Lyrica for pain relief.

** AMAZON.COM INC, $828.52, -0.67 pct

The e-commerce giant said it would hire more than 120,000 seasonal workers in the United States for the holiday season, 20 percent more than last year.

** VERIZON COMMUNICATIONS INC, $50.34, +0.08 pct

The No.1 U.S. wireless company said it would close call centers in five states, including its home state of New York. (Compiled by Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below